| 今开：3.26 | 昨收：3.26 |
| 最高：3.345 | 最低：3.1 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.71661379E8 |
Fate Therapeutics(FATE)05-09 21:05
$Fate Therapeutics(FATE)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-24-134840 Act: 34 Size: 192 KB 网页链接查看全文
Fate Therapeutics(FATE)06-01 05:35
$Fate Therapeutics(FATE)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-151963 Act: 34 Size: 141 KB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:35
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071948 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:35
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071959 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)06-11 05:15
$Fate Therapeutics(FATE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-158427 Act: 33 Size: 67 KB 网页链接查看全文
Fate Therapeutics(FATE)04-27 04:15
$Fate Therapeutics(FATE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118056 Act: 34 Size: 665 KB 网页链接查看全文
Fate Therapeutics(FATE)04-27 04:15
$Fate Therapeutics(FATE)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-117981 Act: 34 Size: 3 MB 网页链接查看全文
Fate Therapeutics(FATE)04-27 04:25
$Fate Therapeutics(FATE)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-118086 Act: 34 Size: 11 MB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:45
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071970 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:35
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071950 Size: 5 KB 网页链接查看全文
美股律师郝俊波2023-03-01 12:59
$Fate Therapeutics(FATE)$ 【Fate Therapeutics(FATE)证券集体诉讼最后20天】
Fate Therapeutics Inc(FATE)因证券欺诈案已经被投资者集体诉讼至法院。在目前的诉讼中投资者指控该公司及部分高管在本案诉讼期间进行虚假陈述，违反证券法令投资者受损。投资者向法院申请判令被告赔偿因其违法行...查看全文
李家村2023-01-10 07:22
$Century Therapeutics(IPSC)$ $Fate Therapeutics(FATE)$
1月5日，Fate Therapeutics（NASDAQ:Fate）和Century Therapeutics (NASDAQ: IPSC, 没有比他的名字更正宗的iPSC公司了) 两家诱导多能干细胞（iPSC）的领头羊明星公司分别发布公告，大幅裁员砍项目消减开支。Fate同时宣布拒绝强生的提...查看全文
逍遥谷-百奥生2023-01-10 01:14
$Fate Therapeutics(FATE)$ 拒绝了JJ的续约条件，股价大幅下跌，是否是个难得的机会呢？就像前一阵的G1$G1治疗(GTHX)$ .建些小仓参与一下。查看全文
空之客2023-01-09 10:01
上周一条引入瞩目的新闻，曾经光芒万丈的细胞治疗新锐公司$Fate Therapeutics(FATE)$ 宣布终止与J&J的合作协议，并终止FT596项目开发，将所剩只够三年运营的$475m现金集中到二代靶向CD19的CAR-NK等项目。
网页链接查看全文
JZee2023-01-08 16:42
有个神秘的事情。木姐本周清仓式狂卖$Fate Therapeutics(FATE)$ ，特别是3号和4号。一部分来补仓$特斯拉(TSLA)$ ，还有的基本也没换什么。然后5号fate和强生合作终止的消息就出来了。这就带来一个问题，木姐是狗屎运，为了补仓特斯拉所以错打错中，还是说木姐用了内幕消息？如果说木姐确实用了内幕...查看全文
交易追踪 ARK 9月3日共有37笔交易，笔数变化不大，个股成交额有所放大，其中，斥资约4000万美元买入美国流媒体领军者Roku，卖出1900万美元加拿大电商服务平台Shopify。此外，还有买入Fate Therapeutics、卖出Square等标的。ARK基金创始人“... 网页链接
$Fate Therapeutics(FATE)$ 内部交易: 2019-10-15,Chief Development Officer,Valamehr Bahram ,卖出,6200普通股, $14.18
$Fate Therapeutics(FATE)$ 内部交易: 2019-10-15,总裁 and CEO,Wolchko J Scott ,卖出,21017普通股, $14.44
$Fate Therapeutics(FATE)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-09-17 AccNo: 0001144204-19-044911 Size: 71 KB 网页链接
$Fate Therapeutics(FATE)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-09-13 AccNo: 0001193125-19-244195 Size: 555 KB 网页链接
$Fate Therapeutics(FATE)$ 8-K - Current report Filed: 2019-09-13 AccNo: 0001193125-19-244198 Size: 313 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Fate Therapeutics(FATE)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-09-11 AccNo: 0001193125-19-242947 Size: 550 KB 网页链接
$Fate Therapeutics(FATE)$ 8-K/A [Amend] - Current report Filed: 2019-08-07 AccNo: 0001564590-19-030033 Size: 312 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Fate Therapeutics(FATE)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-029319 Size: 329 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Fate Therapeutics(FATE)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-06 AccNo: 0001564590-19-029333 Size: 7 MB 网页链接
$Fate Therapeutics(FATE)$ 内部交易: 2019-08-01,Director,Nashat Amir ,卖出,30866普通股, $22.53